Novavax files for authorization of COVID-19 shot amid adolescents in Britain

Novavax Inc said on Wednesday it had filed an application with Britain's drugs regulator for the authorization of its COVID-19 vaccine among adolescents aged 12 and older...

DNA Script, Premas Life Sciences collaborates to provide sales and support for SYNTAX System DNA printer in labs in India

DNA Script, a world leader in Enzymatic DNA Synthesis (EDS) for DNA on demand, has reached a distribution agreement with Premas Life Sciences Pvt. Ltd., India, a leading biotechnology distribution company. This partnership expands DNA Script’s...

Eris Lifesciences acquires Mumbai-based Oaknet Healthcare for 650cr

Branded formulations manufacturer, Eris Lifesciences Ltd on Tuesday acquired a 100% stake in Mumbai-based Oaknet Healthcare Private Ltd for a total consideration of Rs 650 crore....

Pfizer established global drug development centre at IIT Madras Research Park

Pfizer has set up a global drug development centre at the IIT Madras Research Park in Chennai, India...

Bharat Biotech seeks DCGI nod for stage 2/3 Covaxin booster trial among two to 18-year-old

Bharat Biotech has sought permission from India's drug regulator to conduct a phase 2/3 study of its Covid vaccine Covaxin as a booster dose among those aged two to 18 years, sources told PTI...

Aleor Dermaceuticals receives final USFDA approval for new cold sore drug

Alembic Pharmaceuticals Limited (Alembic) announced that its wholly-owned subsidiary, Aleor Dermaceuticals Limited (Aleor) has received final approval from...

Rezolute declares positive results from phase 2B RIZE study of RZ358 in patients with congenital hyperinsulinism

Rezolute, Inc., a clinical-stage biopharmaceutical company, announced positive results from its phase 2b RIZE study of RZ358 in patients with congenital hyperinsulinism (HI), which were unveiled in a late-breaking oral presentation at the Paediatric.

Aurobindo Pharma receives USFDA nod for generic cancer drug Bortezomib

Aurobindo Pharma on Tuesday said its wholly-owned arm Eugia Pharma Specialties Ltd has received final approval from the US health regulator to manufacture and market its generic version of Bortezomib for injection used to treat certain types....

OSE Immunotherapeutics receives European patent covering novel myeloid immune checkpoint target, CLEC-1 for cancer treatment

OSE Immunotherapeutics SA declared the grant of a new patent from the European Patent Office (EPO) strengthening the protection covering its novel myeloid cell immune checkpoint target, CLEC-1 (a C-type lectin receptor), and its use in cancer...

Biocytogen Pharma inks antibody agreement with Merck

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen) announced that it has entered into an evaluation and option agreement with Merck to grant them a sole license to evaluate Biocytogen’s proprietary antibodies against at least three distinct.

© 2025 India Pharma Outlook. All Rights Reserved.